The Institute spans three research disciplines, cardiovascular science, neuroscience and immunology, and will foster multidisciplinary collaborations.
The IDRM is based in the IMS-Tetsuya Nakamura Building on Oxford’s Old Road Campus, between Oxford’s hospitals and alongside the University’s world-leading biosciences, engineering and medical research centres.
The IMS-Tetsuya Nakamura Building was supported by a very generous donation from Dr Tetsuya Nakamura, Chief Director of Itabashi Medical System Group (IMS-Group), and substantial fund-raising from the British Heart Foundation.
Bringing together key insights into the brain, the heart and the immune system, world-leading researchers in the IDRM will come together to meet an urgent unmet clinical need. Two thirds of all deaths world-wide are due to non-communicable cardiovascular, neurological or immunology disorders with a developmental origin. The building, which will house around 240 scientists, is designed to encourage collaborative work between research teams with different disciplines to ultimately develop new drugs and therapeutic strategies to tackle these chronic illnesses. The revolutionary design of the building will ensure that scientists from each section regularly cross paths with and can meet others socially in a way that will foster a cross-pollination of ideas and learnings.
The University of Oxford's newest research institute, the Institute of Developmental & Regenerative Medicine (IDRM), has been officially opened, launching the first institute of its kind in the world to physically merge developmental biology and regenerative medicine to treat some of the world's most prolific diseases.
